ID   PP1G_HUMAN              Reviewed;         323 AA.
AC   P36873;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   10-MAY-2017, entry version 203.
DE   RecName: Full=Serine/threonine-protein phosphatase PP1-gamma catalytic subunit;
DE            Short=PP-1G;
DE            EC=3.1.3.16;
DE   AltName: Full=Protein phosphatase 1C catalytic subunit;
GN   Name=PPP1CC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS GAMMA-1 AND GAMMA-2).
RX   PubMed=8394140; DOI=10.1016/0167-4889(93)90014-G;
RA   Barker H.M., Craig S.P., Spurr N.K., Cohen P.T.W.;
RT   "Sequence of human protein serine/threonine phosphatase 1 gamma and
RT   localization of the gene (PPP1CC) encoding it to chromosome bands
RT   12q24.1-q24.2.";
RL   Biochim. Biophys. Acta 1178:228-233(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM GAMMA-1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-15; 44-60; 99-122; 151-168 AND 247-260, CLEAVAGE
RP   OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [4]
RP   PROTEIN SEQUENCE OF 2-15; 27-36; 44-60; 99-111; 133-141; 151-187 AND
RP   239-260, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Bilsland A.E., Keith W.N.;
RL   Submitted (JAN-2010) to UniProtKB.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 5-323 (ISOFORM GAMMA-1).
RC   TISSUE=Skeletal muscle;
RX   PubMed=8111128; DOI=10.1007/BF00360567;
RA   Norman S.A., Mott D.M.;
RT   "Molecular cloning and chromosomal localization of a human skeletal
RT   muscle PP-1 gamma 1 cDNA.";
RL   Mamm. Genome 5:41-45(1994).
RN   [6]
RP   INTERACTION WITH MICROCYSTIN, AND MUTAGENESIS OF CYS-273.
RX   PubMed=7556599; DOI=10.1016/0014-5793(95)00888-G;
RA   MacKintosh R.W., Dalby K.N., Campbell D.G., Cohen P.T.W., Cohen P.,
RA   MacKintosh C.;
RT   "The cyanobacterial toxin microcystin binds covalently to cysteine-273
RT   on protein phosphatase 1.";
RL   FEBS Lett. 371:236-240(1995).
RN   [7]
RP   INTERACTION WITH PPP1R3D.
RX   PubMed=9414128; DOI=10.1016/S0014-5793(97)01385-9;
RA   Armstrong C.G., Browne G.J., Cohen P., Cohen P.T.W.;
RT   "PPP1R6, a novel member of the family of glycogen-targeting subunits
RT   of protein phosphatase 1.";
RL   FEBS Lett. 418:210-214(1997).
RN   [8]
RP   SUBCELLULAR LOCATION, INTERACTION WITH PPP1R8, AND MUTAGENESIS OF
RP   HIS-125.
RX   PubMed=11739654;
RA   Trinkle-Mulcahy L., Sleeman J.E., Lamond A.I.;
RT   "Dynamic targeting of protein phosphatase 1 within the nuclei of
RT   living mammalian cells.";
RL   J. Cell Sci. 114:4219-4228(2001).
RN   [9]
RP   INTERACTION WITH PPP1R15A.
RX   PubMed=11564868; DOI=10.1128/MCB.21.20.6841-6850.2001;
RA   Connor J.H., Weiser D.C., Li S., Hallenbeck J.M., Shenolikar S.;
RT   "Growth arrest and DNA damage-inducible protein GADD34 assembles a
RT   novel signaling complex containing protein phosphatase 1 and inhibitor
RT   1.";
RL   Mol. Cell. Biol. 21:6841-6850(2001).
RN   [10]
RP   INTERACTION WITH PPP1R7.
RX   PubMed=12226088; DOI=10.1074/jbc.M206838200;
RA   Ceulemans H., Vulsteke V., De Maeyer M., Tatchell K., Stalmans W.,
RA   Bollen M.;
RT   "Binding of the concave surface of the Sds22 superhelix to the alpha
RT   4/alpha 5/alpha 6-triangle of protein phosphatase-1.";
RL   J. Biol. Chem. 277:47331-47337(2002).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12529430; DOI=10.1091/mbc.E02-07-0376;
RA   Trinkle-Mulcahy L., Andrews P.D., Wickramasinghe S., Sleeman J.,
RA   Prescott A., Lam Y.W., Lyon C., Swedlow J.R., Lamond A.I.;
RT   "Time-lapse imaging reveals dynamic relocalization of PP1gamma
RT   throughout the mammalian cell cycle.";
RL   Mol. Biol. Cell 14:107-117(2003).
RN   [12]
RP   INTERACTION WITH NEK2, AND PHOSPHORYLATION.
RX   PubMed=15659832; DOI=10.1196/annals.1329.059;
RA   Fardilha M., Wu W., Sa R., Fidalgo S., Sousa C., Mota C.,
RA   da Cruz e Silva O.A., da Cruz e Silva E.F.;
RT   "Alternatively spliced protein variants as potential therapeutic
RT   targets for male infertility and contraception.";
RL   Ann. N. Y. Acad. Sci. 1030:468-478(2004).
RN   [13]
RP   ENZYME REGULATION.
RX   PubMed=15705855; DOI=10.1126/science.1101902;
RA   Boyce M., Bryant K.F., Jousse C., Long K., Harding H.P., Scheuner D.,
RA   Kaufman R.J., Ma D., Coen D.M., Ron D., Yuan J.;
RT   "A selective inhibitor of eIF2alpha dephosphorylation protects cells
RT   from ER stress.";
RL   Science 307:935-939(2005).
RN   [14]
RP   INTERACTION WITH CDCA2.
RX   PubMed=16492807; DOI=10.1083/jcb.200508154;
RA   Trinkle-Mulcahy L., Andersen J., Lam Y.W., Moorhead G., Mann M.,
RA   Lamond A.I.;
RT   "Repo-Man recruits PP1 gamma to chromatin and is essential for cell
RT   viability.";
RL   J. Cell Biol. 172:679-692(2006).
RN   [15]
RP   INTERACTION WITH NEK2.
RX   PubMed=17283141; DOI=10.1158/0008-5472.CAN-06-3071;
RA   Mi J., Guo C., Brautigan D.L., Larner J.M.;
RT   "Protein phosphatase-1alpha regulates centrosome splitting through
RT   Nek2.";
RL   Cancer Res. 67:1082-1089(2007).
RN   [16]
RP   FUNCTION IN DEPHOSPHORYLATION OF RPS6KB1, ENZYME REGULATION,
RP   INTERACTION WITH URI1, SUBCELLULAR LOCATION, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=17936702; DOI=10.1016/j.molcel.2007.08.010;
RA   Djouder N., Metzler S.C., Schmidt A., Wirbelauer C., Gstaiger M.,
RA   Aebersold R., Hess D., Krek W.;
RT   "S6K1-mediated disassembly of mitochondrial URI/PP1gamma complexes
RT   activates a negative feedback program that counters S6K1 survival
RT   signaling.";
RL   Mol. Cell 28:28-40(2007).
RN   [17]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH NOM1.
RX   PubMed=17965019; DOI=10.1074/jbc.M706708200;
RA   Gunawardena S.R., Ruis B.L., Meyer J.A., Kapoor M., Conklin K.F.;
RT   "NOM1 targets protein phosphatase I to the nucleolus.";
RL   J. Biol. Chem. 283:398-404(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-307, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   IDENTIFICATION IN THE MLL5-L COMPLEX.
RX   PubMed=19377461; DOI=10.1038/nature07954;
RA   Fujiki R., Chikanishi T., Hashiba W., Ito H., Takada I., Roeder R.G.,
RA   Kitagawa H., Kato S.;
RT   "GlcNAcylation of a histone methyltransferase in retinoic-acid-induced
RT   granulopoiesis.";
RL   Nature 459:455-459(2009).
RN   [20]
RP   IDENTIFICATION IN THE PTW/PP1 PHOSPHATASE COMPLEX, FUNCTION, AND
RP   INTERACTION WITH PPP1R8.
RX   PubMed=20516061; DOI=10.1074/jbc.M110.109801;
RA   Lee J.H., You J., Dobrota E., Skalnik D.G.;
RT   "Identification and characterization of a novel human PP1 phosphatase
RT   complex.";
RL   J. Biol. Chem. 285:24466-24476(2010).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [22]
RP   FUNCTION IN CIRCADIAN CLOCK.
RX   PubMed=21712997; DOI=10.1371/journal.pone.0021325;
RA   Schmutz I., Wendt S., Schnell A., Kramer A., Mansuy I.M., Albrecht U.;
RT   "Protein phosphatase 1 (PP1) is a post-translational regulator of the
RT   mammalian circadian clock.";
RL   PLoS ONE 6:E21325-E21325(2011).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-311, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [25]
RP   FUNCTION, INTERACTION WITH FOXP3, AND INDUCTION.
RX   PubMed=23396208; DOI=10.1038/nm.3085;
RA   Nie H., Zheng Y., Li R., Guo T.B., He D., Fang L., Liu X., Xiao L.,
RA   Chen X., Wan B., Chin Y.E., Zhang J.Z.;
RT   "Phosphorylation of FOXP3 controls regulatory T cell function and is
RT   inhibited by TNF-alpha in rheumatoid arthritis.";
RL   Nat. Med. 19:322-328(2013).
RN   [26]
RP   INTERACTION WITH MKI67.
RX   PubMed=24867636; DOI=10.7554/eLife.01641;
RA   Booth D.G., Takagi M., Sanchez-Pulido L., Petfalski E., Vargiu G.,
RA   Samejima K., Imamoto N., Ponting C.P., Tollervey D., Earnshaw W.C.,
RA   Vagnarelli P.;
RT   "Ki-67 is a PP1-interacting protein that organises the mitotic
RT   chromosome periphery.";
RL   Elife 3:E01641-E01641(2014).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-311, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [28]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS, AND ACTIVE SITE.
RX   PubMed=7500362; DOI=10.1006/jmbi.1995.0667;
RA   Egloff M.-P., Cohen P.T.W., Reinemer P., Barford D.;
RT   "Crystal structure of the catalytic subunit of human protein
RT   phosphatase 1 and its complex with tungstate.";
RL   J. Mol. Biol. 254:942-959(1995).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH MANGANESE, AND
RP   COFACTOR.
RX   PubMed=11535607; DOI=10.1074/jbc.M107656200;
RA   Maynes J.T., Bateman K.S., Cherney M.M., Das A.K., Luu H.A.,
RA   Holmes C.F., James M.N.;
RT   "Crystal structure of the tumor-promoter okadaic acid bound to protein
RT   phosphatase-1.";
RL   J. Biol. Chem. 276:44078-44082(2001).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 6-298 IN COMPLEX WITH
RP   MANGANESE, CATALYTIC ACTIVITY, AND COFACTOR.
RX   PubMed=15280359; DOI=10.1074/jbc.M407184200;
RA   Maynes J.T., Perreault K.R., Cherney M.M., Luu H.A., James M.N.,
RA   Holmes C.F.;
RT   "Crystal structure and mutagenesis of a protein phosphatase-
RT   1:calcineurin hybrid elucidate the role of the beta12-beta13 loop in
RT   inhibitor binding.";
RL   J. Biol. Chem. 279:43198-43206(2004).
CC   -!- FUNCTION: Protein phosphatase that associates with over 200
CC       regulatory proteins to form highly specific holoenzymes which
CC       dephosphorylate hundreds of biological targets. Protein
CC       phosphatase 1 (PP1) is essential for cell division, and
CC       participates in the regulation of glycogen metabolism, muscle
CC       contractility and protein synthesis. Dephosphorylates RPS6KB1.
CC       Involved in regulation of ionic conductances and long-term
CC       synaptic plasticity. May play an important role in
CC       dephosphorylating substrates such as the postsynaptic density-
CC       associated Ca(2+)/calmodulin dependent protein kinase II.
CC       Component of the PTW/PP1 phosphatase complex, which plays a role
CC       in the control of chromatin structure and cell cycle progression
CC       during the transition from mitosis into interphase. In balance
CC       with CSNK1D and CSNK1E, determines the circadian period length,
CC       through the regulation of the speed and rhythmicity of PER1 and
CC       PER2 phosphorylation. May dephosphorylate CSNK1D and CSNK1E.
CC       Dephosphorylates the 'Ser-418' residue of FOXP3 in regulatory T-
CC       cells (Treg) from patients with rheumatoid arthritis, thereby
CC       inactivating FOXP3 and rendering Treg cells functionally defective
CC       (PubMed:23396208). {ECO:0000269|PubMed:17936702,
CC       ECO:0000269|PubMed:20516061, ECO:0000269|PubMed:21712997,
CC       ECO:0000269|PubMed:23396208}.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC       {ECO:0000269|PubMed:15280359}.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:11535607,
CC         ECO:0000269|PubMed:15280359};
CC       Note=Binds 2 manganese ions per subunit.
CC       {ECO:0000269|PubMed:11535607, ECO:0000269|PubMed:15280359};
CC   -!- ENZYME REGULATION: Inactivated by binding to URI1. The phosphatase
CC       activity of the PPP1R15A-PP1 complex toward EIF2S1 is specifically
CC       inhibited by Salubrinal, a drug that protects cells from
CC       endoplasmic reticulum stress. {ECO:0000269|PubMed:15705855,
CC       ECO:0000269|PubMed:17936702}.
CC   -!- SUBUNIT: PP1 comprises a catalytic subunit, PPP1CA, PPP1CB or
CC       PPP1CC, which is folded into its native form by inhibitor 2 and
CC       glycogen synthetase kinase 3, and then complexed to one or several
CC       targeting or regulatory subunits. PPP1R12A, PPP1R12B and PPP1R12C
CC       mediate binding to myosin. PPP1R3A (in skeletal muscle), PPP1R3B
CC       (in liver), PPP1R3C, PPP1R3D and PPP1R3F (in brain) mediate
CC       binding to glycogen. Interacts with cyanobacterial toxin
CC       microcystin; disulfide-linked. Interacts with PPP1R3B and PPP1R7.
CC       Isoform gamma-2 interacts with SPZ1 (By similarity). Component of
CC       the MLL5-L complex, at least composed of KMT2E/MLL5, STK38,
CC       PPP1CA, PPP1CB, PPP1CC, HCFC1, ACTB and OGT. Interacts with CDCA2.
CC       PPP1R15A and PPP1R15B mediate binding to EIF2S1. Part of a complex
CC       containing PPP1R15B, PP1 and NCK1/2. Interacts with IKFZ1; the
CC       interaction targets PPP1CC to pericentromeric heterochromatin,
CC       dephosphorylates IKAROS, stabilizes it and prevents it from
CC       degradation. Interacts with PPP1R42; the interaction is direct (By
CC       similarity). Interacts with NOM1 and PPP1R8. Component of the
CC       PTW/PP1 phosphatase complex, composed of PPP1R10/PNUTS, TOX4,
CC       WDR82, and PPP1CA or PPP1CB or PPP1CC. Interacts with PPP1R8.
CC       Interacts with isoform 1 and isoform 4 NEK2. Interacts with URI1;
CC       the interaction is phosphorylation-dependent and occurs in a
CC       growth factor-dependent manner. Interacts with FOXP3. Interacts
CC       with TMEM225 (via RVxF motif) (By similarity). Interacts with
CC       MKI67 (PubMed:24867636). {ECO:0000250|UniProtKB:P63087,
CC       ECO:0000269|PubMed:11535607, ECO:0000269|PubMed:11564868,
CC       ECO:0000269|PubMed:11739654, ECO:0000269|PubMed:12226088,
CC       ECO:0000269|PubMed:15280359, ECO:0000269|PubMed:15659832,
CC       ECO:0000269|PubMed:16492807, ECO:0000269|PubMed:17283141,
CC       ECO:0000269|PubMed:17936702, ECO:0000269|PubMed:17965019,
CC       ECO:0000269|PubMed:19377461, ECO:0000269|PubMed:20516061,
CC       ECO:0000269|PubMed:23396208, ECO:0000269|PubMed:24867636,
CC       ECO:0000269|PubMed:7556599, ECO:0000269|PubMed:9414128}.
CC   -!- INTERACTION:
CC       A1DRY3:-; NbExp=2; IntAct=EBI-3964623, EBI-4311408;
CC       P38398:BRCA1; NbExp=2; IntAct=EBI-356283, EBI-349905;
CC       O95400:CD2BP2; NbExp=3; IntAct=EBI-356283, EBI-768015;
CC       O08785:Clock (xeno); NbExp=2; IntAct=EBI-356283, EBI-79859;
CC       Q96S65:CSRNP1; NbExp=3; IntAct=EBI-356283, EBI-4311573;
CC       Q9H175:CSRNP2; NbExp=5; IntAct=EBI-356283, EBI-5235958;
CC       O15294:OGT; NbExp=11; IntAct=EBI-356283, EBI-539828;
CC       P41236:PPP1R2; NbExp=5; IntAct=EBI-356283, EBI-1056517;
CC       Q7Z5V6:PPP1R32; NbExp=4; IntAct=EBI-3964623, EBI-4311771;
CC       Q15435:PPP1R7; NbExp=3; IntAct=EBI-356283, EBI-1024281;
CC       Q96S59:RANBP9; NbExp=3; IntAct=EBI-3964623, EBI-636085;
CC       Q5JR98:TCTEX1D4; NbExp=3; IntAct=EBI-3964623, EBI-4311709;
CC       P04637:TP53; NbExp=2; IntAct=EBI-356289, EBI-366083;
CC       Q13625:TP53BP2; NbExp=6; IntAct=EBI-356283, EBI-77642;
CC       Q13625-3:TP53BP2; NbExp=3; IntAct=EBI-356283, EBI-10175039;
CC       O94763:URI1; NbExp=15; IntAct=EBI-356283, EBI-357067;
CC       O94763-1:URI1; NbExp=8; IntAct=EBI-356283, EBI-12590720;
CC       O95405:ZFYVE9; NbExp=5; IntAct=EBI-356283, EBI-296817;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Nucleus, nucleolus.
CC       Nucleus, nucleoplasm. Nucleus speckle. Chromosome, centromere,
CC       kinetochore. Cleavage furrow. Midbody. Mitochondrion.
CC       Note=Colocalizes with SPZ1 in the nucleus (By similarity).
CC       Colocalizes with URI1 at mitochondrion. Rapidly exchanges between
CC       the nucleolar, nucleoplasmic and cytoplasmic compartments. Highly
CC       mobile in cells and can be relocalized through interaction with
CC       targeting subunits. In the presence of PPP1R8 relocalizes from the
CC       nucleolus to nuclear speckles. Shows a dynamic targeting to
CC       specific sites throughout the cell cycle. Highly concentrated in
CC       nucleoli of interphase cells and localizes at kinetochores early
CC       in mitosis. Relocalization to chromosome-containing regions occurs
CC       at the transition from early to late anaphase. Also accumulates at
CC       the cleavage furrow and midbody by telophase. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Gamma-1;
CC         IsoId=P36873-1; Sequence=Displayed;
CC       Name=Gamma-2;
CC         IsoId=P36873-2; Sequence=VSP_005094;
CC   -!- INDUCTION: Up-regulated in synovial fluid mononuclear cells and
CC       peripheral blood mononuclear cells from patients with rheumatoid
CC       arthritis. {ECO:0000269|PubMed:23396208}.
CC   -!- PTM: Phosphorylated by NEK2. {ECO:0000269|PubMed:15659832}.
CC   -!- MISCELLANEOUS: Microcystin toxin is bound to Cys-273 through a
CC       thioether bond.
CC   -!- SIMILARITY: Belongs to the PPP phosphatase family. PP-1 subfamily.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=The things we forget -
CC       Issue 32 of March 2003;
CC       URL="http://web.expasy.org/spotlight/back_issues/032";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X74008; CAA52169.1; -; mRNA.
DR   EMBL; BC014073; AAH14073.1; -; mRNA.
DR   EMBL; L07395; AAA19823.1; -; mRNA.
DR   CCDS; CCDS58279.1; -. [P36873-2]
DR   CCDS; CCDS9150.1; -. [P36873-1]
DR   PIR; S35699; S35699.
DR   PIR; S35700; S35700.
DR   RefSeq; NP_001231903.1; NM_001244974.1. [P36873-2]
DR   RefSeq; NP_002701.1; NM_002710.3. [P36873-1]
DR   UniGene; Hs.79081; -.
DR   PDB; 1IT6; X-ray; 2.00 A; A/B=1-323.
DR   PDB; 1JK7; X-ray; 1.90 A; A=1-323.
DR   PDB; 1U32; X-ray; 2.00 A; A=6-298.
DR   PDB; 2BCD; X-ray; 2.10 A; A=1-323.
DR   PDB; 2BDX; X-ray; 2.30 A; A=1-323.
DR   PDB; 4UT2; X-ray; 1.96 A; A/B=1-323.
DR   PDB; 4UT3; X-ray; 2.19 A; A/B=1-323.
DR   PDB; 5INB; X-ray; 1.30 A; A=7-308.
DR   PDB; 5J28; X-ray; 2.00 A; A/B=7-308.
DR   PDBsum; 1IT6; -.
DR   PDBsum; 1JK7; -.
DR   PDBsum; 1U32; -.
DR   PDBsum; 2BCD; -.
DR   PDBsum; 2BDX; -.
DR   PDBsum; 4UT2; -.
DR   PDBsum; 4UT3; -.
DR   PDBsum; 5INB; -.
DR   PDBsum; 5J28; -.
DR   ProteinModelPortal; P36873; -.
DR   SMR; P36873; -.
DR   BioGrid; 111495; 292.
DR   DIP; DIP-749N; -.
DR   IntAct; P36873; 201.
DR   MINT; MINT-190765; -.
DR   STRING; 9606.ENSP00000335084; -.
DR   BindingDB; P36873; -.
DR   ChEMBL; CHEMBL4438; -.
DR   DrugBank; DB02860; Calyculin A.
DR   DrugBank; DB04738; Motuporin.
DR   DEPOD; P36873; -.
DR   iPTMnet; P36873; -.
DR   PhosphoSitePlus; P36873; -.
DR   SwissPalm; P36873; -.
DR   BioMuta; PPP1CC; -.
DR   DMDM; 548573; -.
DR   EPD; P36873; -.
DR   MaxQB; P36873; -.
DR   PaxDb; P36873; -.
DR   PeptideAtlas; P36873; -.
DR   PRIDE; P36873; -.
DR   TopDownProteomics; P36873-1; -. [P36873-1]
DR   TopDownProteomics; P36873-2; -. [P36873-2]
DR   DNASU; 5501; -.
DR   Ensembl; ENST00000335007; ENSP00000335084; ENSG00000186298. [P36873-1]
DR   Ensembl; ENST00000340766; ENSP00000341779; ENSG00000186298. [P36873-2]
DR   GeneID; 5501; -.
DR   KEGG; hsa:5501; -.
DR   UCSC; uc001tru.4; human. [P36873-1]
DR   CTD; 5501; -.
DR   DisGeNET; 5501; -.
DR   GeneCards; PPP1CC; -.
DR   HGNC; HGNC:9283; PPP1CC.
DR   HPA; CAB022645; -.
DR   MIM; 176914; gene.
DR   neXtProt; NX_P36873; -.
DR   OpenTargets; ENSG00000186298; -.
DR   PharmGKB; PA33611; -.
DR   eggNOG; ENOG410IN85; Eukaryota.
DR   eggNOG; ENOG410XPVF; LUCA.
DR   GeneTree; ENSGT00530000062911; -.
DR   HOGENOM; HOG000172697; -.
DR   HOVERGEN; HBG000216; -.
DR   InParanoid; P36873; -.
DR   KO; K06269; -.
DR   OMA; IQRLLEX; -.
DR   OrthoDB; EOG091G0EKF; -.
DR   PhylomeDB; P36873; -.
DR   TreeFam; TF354243; -.
DR   BRENDA; 3.1.3.16; 2681.
DR   Reactome; R-HSA-163560; Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis.
DR   Reactome; R-HSA-2173788; Downregulation of TGF-beta receptor signaling.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-HSA-68877; Mitotic Prometaphase.
DR   SignaLink; P36873; -.
DR   SIGNOR; P36873; -.
DR   ChiTaRS; PPP1CC; human.
DR   EvolutionaryTrace; P36873; -.
DR   GeneWiki; PPP1CC; -.
DR   GenomeRNAi; 5501; -.
DR   PRO; PR:P36873; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000186298; -.
DR   CleanEx; HS_PPP1CC; -.
DR   ExpressionAtlas; P36873; baseline and differential.
DR   Genevisible; P36873; HS.
DR   GO; GO:0032154; C:cleavage furrow; IEA:UniProtKB-SubCell.
DR   GO; GO:0000777; C:condensed chromosome kinetochore; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0043197; C:dendritic spine; IEA:Ensembl.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0030496; C:midbody; IEA:UniProtKB-SubCell.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043234; C:protein complex; IMP:UniProtKB.
DR   GO; GO:0072357; C:PTW/PP1 phosphatase complex; IDA:UniProtKB.
DR   GO; GO:0005521; F:lamin binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016791; F:phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; TAS:Reactome.
DR   GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
DR   GO; GO:0032403; F:protein complex binding; IEA:Ensembl.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0047485; F:protein N-terminus binding; IDA:MGI.
DR   GO; GO:0008157; F:protein phosphatase 1 binding; IEA:Ensembl.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; IMP:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; ISS:UniProtKB.
DR   GO; GO:0005977; P:glycogen metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0030182; P:neuron differentiation; IEA:Ensembl.
DR   GO; GO:0006470; P:protein dephosphorylation; IMP:MGI.
DR   GO; GO:0042752; P:regulation of circadian rhythm; IMP:UniProtKB.
DR   GO; GO:0046822; P:regulation of nucleocytoplasmic transport; IEA:Ensembl.
DR   GO; GO:0007062; P:sister chromatid cohesion; TAS:Reactome.
DR   Gene3D; 3.60.21.10; -; 1.
DR   InterPro; IPR004843; Calcineurin-like_PHP_ApaH.
DR   InterPro; IPR029052; Metallo-depent_PP-like.
DR   InterPro; IPR006186; Ser/Thr-sp_prot-phosphatase.
DR   InterPro; IPR031675; STPPase_N.
DR   Pfam; PF00149; Metallophos; 1.
DR   Pfam; PF16891; STPPase_N; 1.
DR   PRINTS; PR00114; STPHPHTASE.
DR   SMART; SM00156; PP2Ac; 1.
DR   SUPFAM; SSF56300; SSF56300; 1.
DR   PROSITE; PS00125; SER_THR_PHOSPHATASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Biological rhythms;
KW   Carbohydrate metabolism; Cell cycle; Cell division; Centromere;
KW   Chromosome; Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Disulfide bond; Glycogen metabolism; Hydrolase; Kinetochore;
KW   Manganese; Metal-binding; Mitochondrion; Nucleus; Phosphoprotein;
KW   Polymorphism; Protein phosphatase; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|Ref.3, ECO:0000269|Ref.4}.
FT   CHAIN         2    323       Serine/threonine-protein phosphatase PP1-
FT                                gamma catalytic subunit.
FT                                /FTId=PRO_0000058787.
FT   ACT_SITE    125    125       Proton donor.
FT                                {ECO:0000269|PubMed:7500362}.
FT   METAL        64     64       Manganese 1.
FT                                {ECO:0000269|PubMed:11535607,
FT                                ECO:0000269|PubMed:15280359}.
FT   METAL        66     66       Manganese 1.
FT                                {ECO:0000269|PubMed:11535607,
FT                                ECO:0000269|PubMed:15280359}.
FT   METAL        92     92       Manganese 1.
FT                                {ECO:0000269|PubMed:11535607,
FT                                ECO:0000269|PubMed:15280359}.
FT   METAL        92     92       Manganese 2.
FT                                {ECO:0000269|PubMed:11535607,
FT                                ECO:0000269|PubMed:15280359}.
FT   METAL       124    124       Manganese 2.
FT                                {ECO:0000269|PubMed:11535607,
FT                                ECO:0000269|PubMed:15280359}.
FT   METAL       173    173       Manganese 2.
FT                                {ECO:0000269|PubMed:11535607,
FT                                ECO:0000269|PubMed:15280359}.
FT   METAL       248    248       Manganese 2.
FT                                {ECO:0000269|PubMed:11535607,
FT                                ECO:0000269|PubMed:15280359}.
FT   SITE        273    273       Inhibition by microcystin toxin binding.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|Ref.3, ECO:0000269|Ref.4}.
FT   MOD_RES     307    307       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     311    311       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ     315    323       GMITKQAKK -> VASGLNPSIQKASNYRNNTVLYE (in
FT                                isoform Gamma-2).
FT                                {ECO:0000303|PubMed:8394140}.
FT                                /FTId=VSP_005094.
FT   VARIANT     152    152       F -> S (in dbSNP:rs11558237).
FT                                /FTId=VAR_051734.
FT   MUTAGEN     125    125       H->A: Loss of activity.
FT                                {ECO:0000269|PubMed:11739654}.
FT   MUTAGEN     273    273       C->A,S,L: Abolishes interaction with
FT                                microcystin toxin.
FT                                {ECO:0000269|PubMed:7556599}.
FT   HELIX         9     17       {ECO:0000244|PDB:5INB}.
FT   HELIX        18     21       {ECO:0000244|PDB:5INB}.
FT   HELIX        32     48       {ECO:0000244|PDB:5INB}.
FT   STRAND       51     55       {ECO:0000244|PDB:5INB}.
FT   STRAND       57     62       {ECO:0000244|PDB:5INB}.
FT   HELIX        69     79       {ECO:0000244|PDB:5INB}.
FT   STRAND       87     89       {ECO:0000244|PDB:5INB}.
FT   STRAND       94     98       {ECO:0000244|PDB:5INB}.
FT   HELIX       100    113       {ECO:0000244|PDB:5INB}.
FT   TURN        115    117       {ECO:0000244|PDB:5INB}.
FT   STRAND      118    120       {ECO:0000244|PDB:5INB}.
FT   HELIX       128    131       {ECO:0000244|PDB:5INB}.
FT   TURN        132    135       {ECO:0000244|PDB:4UT3}.
FT   HELIX       136    143       {ECO:0000244|PDB:5INB}.
FT   HELIX       146    156       {ECO:0000244|PDB:5INB}.
FT   STRAND      162    165       {ECO:0000244|PDB:5INB}.
FT   TURN        166    168       {ECO:0000244|PDB:5INB}.
FT   STRAND      169    174       {ECO:0000244|PDB:5INB}.
FT   HELIX       183    187       {ECO:0000244|PDB:5INB}.
FT   STRAND      197    199       {ECO:0000244|PDB:5INB}.
FT   HELIX       200    206       {ECO:0000244|PDB:5INB}.
FT   STRAND      214    218       {ECO:0000244|PDB:5INB}.
FT   STRAND      222    227       {ECO:0000244|PDB:5INB}.
FT   HELIX       229    239       {ECO:0000244|PDB:5INB}.
FT   STRAND      243    246       {ECO:0000244|PDB:5INB}.
FT   STRAND      254    258       {ECO:0000244|PDB:5INB}.
FT   TURN        259    262       {ECO:0000244|PDB:5INB}.
FT   STRAND      263    267       {ECO:0000244|PDB:5INB}.
FT   HELIX       272    274       {ECO:0000244|PDB:5INB}.
FT   STRAND      280    285       {ECO:0000244|PDB:5INB}.
FT   STRAND      290    298       {ECO:0000244|PDB:5INB}.
SQ   SEQUENCE   323 AA;  36984 MW;  0EEEF0E842188536 CRC64;
     MADLDKLNID SIIQRLLEVR GSKPGKNVQL QENEIRGLCL KSREIFLSQP ILLELEAPLK
     ICGDIHGQYY DLLRLFEYGG FPPESNYLFL GDYVDRGKQS LETICLLLAY KIKYPENFFL
     LRGNHECASI NRIYGFYDEC KRRYNIKLWK TFTDCFNCLP IAAIVDEKIF CCHGGLSPDL
     QSMEQIRRIM RPTDVPDQGL LCDLLWSDPD KDVLGWGEND RGVSFTFGAE VVAKFLHKHD
     LDLICRAHQV VEDGYEFFAK RQLVTLFSAP NYCGEFDNAG AMMSVDETLM CSFQILKPAE
     KKKPNATRPV TPPRGMITKQ AKK
//
